The inventory of antibiotics in Russian home medicine cabinets

Clinical Infectious Diseases

Volumn 37, Issue 4, 2003, Pages 498-505

  Stratchounski, Leonid S ^a   Andreeva, I V ^a   Ratchina, S A ^a   Galkin, D V ^a   Petrotchenkova, N A ^a   Demin, A A ^b   Kuzin, V B ^c   Kusnetsova, S T ^d   Likhatcheva, R Y ^e   Nedogoda, S V ^f   Ortenberg, E A ^g   Belikov, A S ^h   Toropova, I A ⁱ  

^a SMOLENSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^b NOVOSIBIRSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^c PRIVOLZHSKY RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^d URAL STATE MEDICAL UNIVERSITY   (Russian Federation)

^e Moscow City Clinical Hospital No 59 Moscow   (Russian Federation)

^f VOLGOGRAD STATE MEDICAL UNIVERSITY   (Russian Federation)

^g TYUMEN STATE MEDICAL UNIVERSITY   (Russian Federation)

^h Inst of Antimicrobial Chemotherapy   (Russian Federation)

ⁱ Pediatric Department   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BENZATHINE PENICILLIN; CEFAZOLIN; CHLORAMPHENICOL; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FURAZOLIDONE; LINCOMYCIN; PENICILLIN G; SULFANILAMIDE; TETRACYCLINE;

ANTIBIOTIC THERAPY; ARTICLE; DRUG INDICATION; DRUG MISUSE; ENTEROPATHY; FEVER; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RUSSIAN FEDERATION; SELF MEDICATION; SORE THROAT;

AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHLORAMPHENICOL; DRUG RESISTANCE, MICROBIAL; EQUIPMENT AND SUPPLIES; ERYTHROMYCIN; HUMANS; RUSSIA; SELF MEDICATION; TETRACYCLINE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0041440241     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/376905     Document Type: Article

References (37)

1. Antibactieral drugs. Labelling requirements: information on drug-resistant bacteria. WHO Pharmaceuticals Newsletter. 2000;4:1. Available at: http://www.who.int/medicines/organization/qsm/activities/drugsafety/ orgpharmanews.shtml.
2. Improved use of antimicrobials needed to combat drug resistance. In: Proceedings of the 30th International Educational and Scientific Symposium of the Society of Critical Care Medicine (San Francisco). Des Plaines, IL: Society of Critical Care Medicine, 2001.
3. Levy S. Antibiotic resistance: an ecological imbalance. Ciba Found Symp 1997; 207:1-14.
4. Liu Y, Huang W, Huang T, Kunin C. Inappropriate use of antibiotics and the risk for delayed admission and masked diagnosis of infectious diseases: a lesson from Taiwan. Arch Intern Med 2001; 161:2366-70.
5. Eandi M, Zara GP. Economic impact of resistance in the community. Int J Clin Pract Suppl 1998; 95:27-38.
6. Hellinger WC. Confronting the problem of increasing antibiotic resistance. South Med J 2000; 93:842-8.
7. Garcia-Altes A, Jovell AJ, Aymerich M. The other side of the coin: socioeconomic analysis of antibiotic resistance [in Spanish]. Enferm Infecc Microbiol Clin 1999; 17:27-31.
8. Marliere G, Ferraz M, dos Santos J. Antibiotic consumption patterns and drug leftovers in 6000 Brazilian households. Adv Ther 2000; 17:32-44.
9. Wenzel R, Edmond M. Managing antibiotic resistance. N Engl J Med 2000; 343:1961-3.
10. Rubinstein E, Ronald A. Toronto declaration to combat antimicrobial resistance. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 2000.
11. Sturm A, van der Pol R, Smits A, et al. Over-the-counter availability of antimicrobial agents, self-medication and patterns of resistance in Karachi, Pakistan. J Antimicrob Chemother 1997; 39:543-7.
12. Mainous A, Hueston W. Controlling antibiotic resistance: will we someday see limited prescribing autonomy? Am Fam Physician 2001; 63:1034, 1036, 1039.
13. Calva J, Bojalil R. Antibiotic use in a periurban community in Mexico: a household and drugstore survey. Soc Sci Med 1996; 42:1121-8.
14. Orero Gonzalez A, Ripoll Lozano M, Gonzalez Nunez J. Analysis of automedication with antibiotics in Spain [in Spanish]. Enferm Infecc Microbiol Clin 1998; 16:328-33.
15. McKee M, Mills L, Mainous A. Antibiotic use for the treatment of upper respiratory infections in a diverse community. J Fam Pract 1999; 48:993-6.
16. Gannon J. The global infectious disease threat and its implications for the United States. Washington, DC: National Intelligence Council, 2000. Available at: http://www.cia.gov/cia/publications/nie/report/nie99-17d.html.
17. European Surveillance of Antibiotic Consumption (ESAC). Project description. Antwerp, Belgium: University of Antwerp, Medical Microbiology, 2001. Available at: http://esac-www.uia.ac.be/esac/ESAC_project.htm.
18. Roujeau J, Kelly J, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333:1600-7.
19. Mockenhaupt M, Schopf E. Progress in allergy and clinical immunology. In: Proceedings of the 16th International Congress of Allerology and Clinical Immunology (Cancun, Mexico). Milwaukee: International Association of Allerology and Clinical Immunology-World Allergy Organization, 1997:352-60.
20. Sturchler D, Mittelholzer M, Kerr L. How frequent are notified severe cutaneous adverse reactions to Fansidar? Drug Saf 1993; 8:160-8.
21. Smith A, Dovey G, Cartwright R. Topical chloramphenicol and the risk of acute laeukaemla in adults. Pharmacoepidemiol Drug Safe 2000; 9:215-9.
22. Vincent P. Drug-induced aplastic anaemia and agranulocytosis: incidence and mechanisms. Drugs 1986; 31:52-63.
23. Casale T. Aplastic anemia: the disease and its management. Postgrad Med 1982; 71:59-70.
24. Ratchina S. Patterns of drug use in children in Russia [abstract 15]. In: Proceedings of the 5th Congress of the European Association for Clinical Pharmacology and Therapeutics (Odense, Denmark). European Association for Clinical Pharmacology and Therapeutics, 2001: 15.
25. Alexandrova E. For head, abdomen and heart [in Russian]. Monitor 1999; 153:28.
26. Androsova S. Forming the home medicine cabinet [in Russian]. Women's Passions 2000. Available at: http://www.passion.ru/money/pharm.htm.
27. Ceaser S, Wurtz R. "Leftover" antibiotics in the medicine cabinet. Ann Intern Med 2000; 133:74.
28. Richman P, Garra G, Eskin B, Nashed A, Cody R. Oral antibiotic use without consulting a physician: a survey of ED patients. Am J Emerg Med 2001; 19:57-60.
29. Sweden to monitor antibiotic use. SCRIP. 2000; 2561:6.
30. Macfarlane J, Holmes W, Gard P, et al. Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet. BMJ 2002; 324:91.
31. Spain begins antibiotics rational use campaign. SCRIP 2001; 2614:4.
32. World Health Organization. WHO global strategy for the containment of antimicrobial resistance. 11 September 2001. Available at: http://www.who.int/csr/drugresist/guidance/en/.
33. Samaranayake L, Johnson N. Guidelines for the use of antimicrobial agents to minimize development of resistance. Int Dent J 1999; 49:189-95.
34. Nilsson G, Hjemdahl P, Hassler A, et al. Feedback on prescribing rate combined with problem-oriented pharmacotherapy education as a model to improve prescribing behaviour among general practitioners. Eur J Clin Pharmacol 2001; 56:843-8.
35. Metersky M, Galusha DH, Meehan TP. Improving the care of patients with community-acquired pneumonia: a multihospital collaborative QT project. Jt Comm J Qual Improv 1999; 25:182-90.
36. Coley K, Skledar S, Fine M, et al. Changing physician prescribing behavior: the community-acquired pneumonia interventional trial. Am J Health Syst Pharm 2000; 57:1506-10.
37. Seppala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337:441-6.